Quarterly report pursuant to Section 13 or 15(d)

4. Acquisitions (Details Narrative)

v3.19.3
4. Acquisitions (Details Narrative) - USD ($)
3 Months Ended 7 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Jul. 19, 2019
Sep. 30, 2019
Sep. 30, 2018
Research and development expense $ 3,520,638 $ 735,879   $ 4,471,939 $ 2,369,219
General and administrative expense $ 2,142,505 $ 1,079,008   3,896,657 $ 3,267,597
XCART Technology [Member]          
Payment for intellectual property     $ 4,100,000    
Research and development expense       3,000,000  
General and administrative expense       $ 1,100,000  
Hesperix [Member]          
Stock issued for acquisition, shares     406,246    
OPKO Assignment Agreement [Member]          
Stock issued for acquisition, shares     164,062    
Institute [Member]          
Stock issued for acquisition, shares     54,687